DTU Director Professor Rury Holman, Head of Development Joanne Keenan and Head of Clinical Research Zoe Doran have accompanied Oxford's Vice-Chancellor Professor Andrew Hamilton and researchers from the Nuffield Department of Medicine (NDM) on a visit to China.
The team took part in an event in Beijing on 14th May to celebrate Oxford University and China's research collaborations in the field of medical sciences. The event showcased medical scientists from NDM who are collaborating with colleagues in China on a variety of projects, from diabetes and cardiovascular disease, to infectious diseases and depression.
During his visit, Professor Hamilton also officially launched the new offices of Oxford University Beijing and Science Technology Company Ltd, a wholly-owned subsidiary of the University of Oxford in Beijing, created to support increased academic activity in China.
DTU is already collaborating with China through the ACE (Acarbose Cardiovascular Evaluation) study, the first Chinese cardiovascular outcome trial in people with cardiovascular disease and impaired glucose tolerance. The ACE trial, which started in 2008 and runs until 2017, is finding out if the drug acarbose can prevent further heart disease and strokes, and delay the onset of diabetes. This large-scale trial is recruiting 7,500 patients from 150 hospitals across China.
The picture shows, from left to right: Professor Peter Ratcliffe, Head of NDM; Professor Andrew Hamilton, Vice-Chancellor; and Professor Rury Holman, Director of DTU.
To find out more about NDM's work in China, see